SEC Form 4 research

AGIOS PHARMACEUTICALS INC insider transactions

Recent insider disclosures

Officers and directors in the directory

• Scadden David — 8 qualifying
• Goff Brian — 21 qualifying
• Washburn Theodore James Jr. — 24 qualifying
• Foster-Cheek Kaye I — 25 qualifying
• Milanova Tsveta — 11 qualifying
• Jones Cecilia — 15 qualifying
• Gheuens Sarah — 24 qualifying
• Bowden Christopher — 38 qualifying
• Alenson Carman — 12 qualifying
• Ballal Rahul D. — 17 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.